Markets.News
On January 26, 2026, in Chino, California, Pepzyme AG™, a proteolytic enzyme blend developed by Specialty Enzymes & Probiotics, is being highlighted for its ability to provide crucial support to GLP-1 users. This support includes assistance in superior collagen digestion and improved metabolic function. The effectiveness of Pepzyme AG™ is reinforced by scientific research that has been published and peer-reviewed.